ArticleInternational journal of molecular sciences2024
Porter 6: Protein Secondary Structure Prediction by Leveraging Pre-Trained Language Models (PLMs).
Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Deep learning architectures achieve state-of-the-art (SOTA) accuracy in protein secondary structure prediction.Molecular diversity · 2026Review
- Scaling SMILES-based chemical language models for therapeutic peptide engineering.bioRxiv : the preprint server for biology · 2026Article
- TruMPET: A New Method for Protein Secondary Structure Prediction Using Neural Networks Trained on Multiple Pre-Selected Physicochemical and Structural Features.International journal of molecular sciences · 2025Article
- Advancements in one-dimensional protein structure prediction using machine learning and deep learning.Computational and structural biotechnology journal · 2025Review
- Comprehensive assessment of AlphaFold's predictions of secondary structure and solvent accessibility at the amino acid-level in eukaryotic, bacterial and archaeal proteins.Computational and structural biotechnology journal · 2025Article
- DeepPredict: a state-of-the-art web server for protein secondary structure and relative solvent accessibility prediction.Frontiers in bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Accurately predicting protein secondary structure (PSSP) is crucial for understanding protein function, which is foundational to advancements in drug development, disease treatment, and biotechnology. Researchers gain critical insights into protein folding and function within cells by predicting protein secondary structures. The advent of deep learning models, capable of processing complex sequence data and identifying meaningful patterns, offer substantial potential to enhance the accuracy and efficiency of protein structure predictions. In particular, recent breakthroughs in deep learning-driven by the integration of natural language processing (NLP) algorithms-have significantly advanced the field of protein research. Inspired by the remarkable success of NLP techniques, this study harnesses the power of pre-trained language models (PLMs) to advance PSSP prediction. We conduct a comprehensive evaluation of various deep learning models trained on distinct sequence embeddings, including one-hot encoding and PLM-based approaches such as ProtTrans and ESM-2, to develop a cutting-edge prediction system optimized for accuracy and computational efficiency. Our proposed model, Porter 6, is an ensemble of CBRNN-based predictors, leveraging the protein language model ESM-2 as input features. Porter 6 achieves outstanding performance on large-scale, independent test sets. On a 2022 test set, the model attains an impressive 86.60% accuracy in three-state (Q3) and 76.43% in eight-state (Q8) classifications. When tested on a more recent 2024 test set, Porter 6 maintains robust performance, achieving 84.56% in Q3 and 74.18% in Q8 classifications. This represents a significant 3% improvement over its predecessor, outperforming or matching state-of-the-art approaches in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.